Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Dutasteride may help shrink prostate cancer tumors.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Vertex pattern hair loss linked to higher prostate cancer risk.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Onions may help reduce cancer risk and obesity-related issues.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Steroid hormones can help treat aging issues and improve health in elderly people.

Male pattern baldness does not cause an increased risk of prostate cancer.

The document suggests using natural remedies like bloodletting and honey for various health issues but lacks scientific evidence for their effectiveness.

Finasteride reduces prostate size and PSA levels in young patients.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Finasteride may worsen infertility in men with existing issues, but stopping it can improve sperm health.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.